CHRNA4 and Alzheimer disease: Therefore, although nAChR crosstalk with the endocannabinoid system may not be directly related to AD, this highlights the potential for the cannabinoid system to influence global cholinergic signalling and is thus a crucial consideration in the use of cannabinoids to target the cholinergic system in AD.